MSCgo™ Osteogenic Differentiation Medium
Complete, serum-free, xeno-free, ready-to-use medium, Optimized for directed differentiation of hMSCs to osteoblasts
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
MSCgo™ Osteogenic Differentiation Medium is a serum-free (SF), xeno-free (XF), complete, and ready to use formulation developed for optimal differentiation of human mesenchymal stem cells (hMSC) to mature osteocytes.
The MSCgo™ Osteogenic Differentiation Medium is validated to efficiently differeniate hMSC from a variety of sources, including bone marrow (BM-MSC), adipose tissue (AT-MSC), and umbilical cord tissue (UC-MSC).
The MSCgo™ Osteogenic Differentiation protocol is part of a complete system for multipotency evaluation of hMSCs. The MSCgo™ Osteogenic Differentiation Medium enables reliable osteogenesis if hMSCs. Differentiation to mature osteocytes is seen between 14 and 21 days.
Features:
- Serum-free, xeno-free solution
Xeno-Free Stem Cell Media Range Offered by Biological Industries
hESC and hiPSC research is one of the most dynamic fields in modern biology, but cell-based clinical applications are currently limited by xeno contamination during the in vitro derivation and propagation phases. Thus, bridging the gap between research models and clinical applications requires the design and implementation of qualified protocols and operating processes. Xeno-free or animal-component-free media is an essential element in the development of regenerative stem cell therapies where implantation in humans is the desired outcome.
